The Ruđer Bošković Institute is regarded as Croatia’s leading multidisciplinary scientific institute in the natural and biomedical sciences. The institute is the leading and internationally most competitive Croatian institute by virtue of its participation in international research projects, such as the EC FP5-7 programmes funded by the European Commission and partnerships with the IAEA, NATO, NSF, SNSF, DAAD and other international scientific foundations. Today, the Ruđer Bošković Institute has over 550 scientists and researchers in more than 80 laboratories pursuing research and development in theoretical and experimental physics, physics and materials chemistry, electronics, physical chemistry, organic chemistry and biochemistry, molecular biology and medicine, the sea and the environment, informational and computer sciences, and laser and nuclear sciences.

Research in the Radiation Chemistry and Dosimetry Laboratory (RCDL) is focused on the physical-chemical effects of ionising radiation for fundamental and applied science. The following areas comprise the research interests of the RCDL: development of measurement methods for determination of the amount of energy deposited by ionising radiation in irradiated matter (dosimetry); characterization of both dosimetry systems and radiation fields; dosimetry of electromagnetic and particulate radiations, both neutral (neutrons) and charged particles (electrons and heavy ions); and passive solid-state and chemical dosimetry. In addition, the RCDL is involved in medical dosimetry, radiation processing, and individual and environmental dosimetry monitoring.

Dosimetry group interests within the Radiation Chemistry and Dosimetry Laboratory concern solid-state dosimetry, primarily thermoluminescence and radiophotoluminescence dosimetry, and its various applications especially in regards to the medical field. Dosimetry group research is dedicated to radiation dosimetry and protection, especially in medicine, in continuous activities through EURADOS. The group was among the first in the EU to establish a new dosimetry method using radiophotoluminescence.

Members of the group are participating in the projects and measurement campaigns within EURADOS WG 9 Dosimetry in radiotherapy and WG 12 Dosimetry in medical imaging. The present topic of both WGs, also identified as priorities within the radiation research community, is focused on increasing knowledge on radiation doses during medical examinations, both in imaging and radiotherapy, and their related risks. The member participates in the EURADOS development of the medical part of SRA.